Arcus Biosciences (RCUS) Other Gross PP&E Adjustments (2017 - 2024)
Historic Other Gross PP&E Adjustments for Arcus Biosciences (RCUS) over the last 8 years, with Q4 2024 value amounting to $61.0 million.
- Arcus Biosciences' Other Gross PP&E Adjustments changed 0.0% to $61.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $61.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $61.0 million for FY2024, which is 0.0% changed from last year.
- According to the latest figures from Q4 2024, Arcus Biosciences' Other Gross PP&E Adjustments is $61.0 million, which was down 0.0% from $61.0 million recorded in Q4 2023.
- In the past 5 years, Arcus Biosciences' Other Gross PP&E Adjustments ranged from a high of $61.0 million in Q4 2023 and a low of -$104.3 million during Q2 2022
- Over the past 5 years, Arcus Biosciences' median Other Gross PP&E Adjustments value was -$6.5 million (recorded in 2020), while the average stood at -$20.7 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first tumbled by 834233.41% in 2021, then soared by 16464.72% in 2022.
- Quarter analysis of 5 years shows Arcus Biosciences' Other Gross PP&E Adjustments stood at $8.5 million in 2020, then plummeted by 865.59% to -$65.0 million in 2021, then soared by 164.65% to $42.0 million in 2022, then soared by 45.24% to $61.0 million in 2023, then changed by 0.0% to $61.0 million in 2024.
- Its Other Gross PP&E Adjustments stands at $61.0 million for Q4 2024, versus $61.0 million for Q4 2023 and $42.0 million for Q4 2022.